{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:46:17Z","timestamp":1762101977549,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T00:00:00Z","timestamp":1487116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ajog.2017.02.024","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T21:33:40Z","timestamp":1487626420000},"page":"608.e1-608.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Topical application of recombinant activated factor VII during cesarean delivery for placenta previa"],"prefix":"10.1016","volume":"216","author":[{"given":"Birgit T.B.G.","family":"Schjoldager","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmeli","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malene R.","family":"Lykke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen","family":"Pr\u00e6st","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Mette","family":"Hvas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Heslet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels J.","family":"Secher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jannie D.","family":"Salvig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6449-6426","authenticated-orcid":false,"given":"Niels","family":"Uldbjerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2017.02.024_bib1","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1399-6576.2010.02309.x","article-title":"Management of post-partum hemorrhage","volume":"54","author":"Ahonen","year":"2010","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.ajog.2017.02.024_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/jmf.13.3.175.190","article-title":"Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies","volume":"13","author":"Faiz","year":"2003","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2017.02.024_bib3","first-page":"525914","article-title":"Severe postpartum hemorrhage from uterine atony: a multicentric study","volume":"2013","author":"Montufar-Rueda","year":"2013","journal-title":"J\u00a0Pregnancy"},{"key":"10.1016\/j.ajog.2017.02.024_bib4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/ACO.0b013e3283532007","article-title":"The role of recombinant activated factor VII in obstetric hemorrhage","volume":"25","author":"Ahonen","year":"2012","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.ajog.2017.02.024_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000338034","article-title":"Use of activated recombinant factor VII in severe bleeding\u2013evidence for efficacy and safety in trauma, postpartum hemorrhage, cardiac surgery, and gastrointestinal bleeding","volume":"39","author":"Lau","year":"2012","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.ajog.2017.02.024_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/aogs.12798","article-title":"Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials","volume":"95","author":"Simonazzi","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2017.02.024_bib7","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1182\/blood.V81.3.734.734","article-title":"Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation","volume":"81","author":"Morrissey","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2017.02.024_bib8","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/0029-7844(94)00231-2","article-title":"A\u00a0thrombogene uterin pack for postpartum hemorrhage","volume":"85","author":"Bobrowski","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.02.024_bib9","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/AOG.0b013e3181e772cf","article-title":"Use of hemostatic gel in postpartum hemorrhage due to placenta previa","volume":"116","author":"Law","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.02.024_bib10","first-page":"271","article-title":"Gelatin-thrombin hemostatic matrix in the management of placental site postpartum hemorrhage: a case report","volume":"56","author":"Wohlmuth","year":"2011","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ajog.2017.02.024_bib11","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3109\/00016349.2010.485630","article-title":"New local hemostatic treatment for postpartum hemorrhage caused by placenta previa at cesarean section","volume":"89","author":"Fuglsang","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2017.02.024_bib12","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/j.ajog.2011.09.018","article-title":"Postpartum hemorrhage: use of hemostatic combat gauze","volume":"206","author":"Schmid","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.02.024_bib13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ajog.2014.12.029","article-title":"Use of Monsel\u2019s solution to treat obstetrical hemorrhage: a review and comparison to other topical hemostatic agents","volume":"212","author":"Miller","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.02.024_bib14","first-page":"1087","article-title":"Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis","volume":"134","author":"Drake","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajog.2017.02.024_bib15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.ATV.0000130465.23430.74","article-title":"Role of tissue factor in hemostasis, thrombosis, and vascular development","volume":"24","author":"Mackman","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajog.2017.02.024_bib16","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1213\/ane.0b013e31819bceb1","article-title":"The role of tissue factor and factor VIIa in hemostasis","volume":"108","author":"Mackmann","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ajog.2017.02.024_bib17","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0002-9378(12)90756-5","article-title":"Amniotic fluid contains tissue factor, a potent initiator of coagulation","volume":"165","author":"Lockwood","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.02.024_bib18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.thromres.2014.10.014","article-title":"Activation contact system (ACS) and tissue factor (TF) in human amniotic fluid: measurements of ACS components and TF, and some implications on the pathophysiology of amniotic fluid embolism","volume":"135","author":"Uszy\u0144ski","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2017.02.024_bib19","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1073\/pnas.96.14.8138","article-title":"Tissue factor is required for uterine hemostasis and maintenance of the placenta labyrinth during gestation","volume":"96","author":"Erlich","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2017.02.024_bib20","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.thromres.2009.07.017","article-title":"Involvement of human decidual cell-expressed tissue factor in uterine hemostasis and abruption","volume":"124","author":"Lockwood","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2017.02.024_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/humupd\/dmw004","article-title":"The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding","volume":"22","author":"Schatz","year":"2016","journal-title":"Hum Reprod Update"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817302934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817302934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:14:26Z","timestamp":1757589266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937817302934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0002937817302934"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2017.02.024","relation":{},"ISSN":["0002-9378"],"issn-type":[{"type":"print","value":"0002-9378"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical application of recombinant activated factor VII during cesarean delivery for placenta previa","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2017.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}